Journal of Medicinal Chemistry · 2000 · 184 citations · 45 references
PharmacyBiochemistryMedicinal ChemistryComputational Medicinal ChemistryDrug DesignDrug DiscoveryLigand BindingLigand-based DesignProtein StructureProtein-ligand DockingProtein-ligand RecognitionActive Site AnalysisChemical Structure-activity RelationshipsEnzyme SelectivityEnzyme Selectivity DesignProtein TargetsStructure-based Ligand DesignStructure-based Selectivity DesignTarget Selectivity Analysis
We present a computational procedure aimed at understanding enzyme selectivity and guiding the design of drugs with respect to selectivity. It starts from a set of 3D structures of the target proteins characterized by the program GRID. In the multivariate description proposed, the variables are organized and scaled in a different way than previously published methodologies. Then, consensus principal component analysis (CPCA) is used to analyze the GRID descriptors, allowing the straightforward identification of possible modifications in the ligand to improve its selectivity toward a chosen target. As an important new feature the computational method is able to work with more than two target proteins and with several 3D structures for each protein. Additionally, the use of a 'cutout tool' allows to focus on the important regions around the active site. The method is validated for a total number of nine structures of the three homologous serine proteases thrombin, trypsin, and factor Xa. The regions identified by the method as being important for selectivity are in excellent agreement with available experimental data and inhibitor structure-activity relationships.
45
Svante Wold, Kim H. Esbensen, Paul Geladi · Chemometrics and Intelligent Laboratory Systems · 1987 · 11.5K citations
Markus Böhm, Jörg Stürzebecher, G. Klebe · Journal of Medicinal Chemistry · 1999 · 441 citations · Full text
Structure of Human Des(1-45) Factor Xa at 2·2 Å Resolution
K. Padmanabhan, K. Padmanabhan, A. Tulinsky et al. · Journal of Molecular Biology · 1993 · 392 citations